Jalen Carter Ruled Out for Eagles vs. Chargers After Surgery

URGENT UPDATE: The Philadelphia Eagles will face a significant setback in Week 14 as defensive tackle Jalen Carter has been officially ruled out of the upcoming clash against the Los Angeles Chargers on Monday night. This news comes on the heels of a tough Thanksgiving loss to the Dallas Cowboys, adding pressure to the Eagles’ playoff aspirations.

According to ESPN’s Adam Schefter, Carter underwent medical procedures on both shoulders and will be sidelined as he continues treatment. The decision to proceed with surgery appears aimed at ensuring Carter is fully healthy for a crucial playoff run, but it could result in him missing multiple weeks, not just Monday’s game.

Despite the severity of his condition, Schefter reports that the Eagles do not intend to place Carter on injured reserve, leaving the door open for a potential return at any point this season. This could be a relief for Eagles fans who have seen Carter excel in his 2025 season, amassing 32 total tackles and two sacks, along with a blocked kick.

The Eagles’ fanbase is understandably upset, expressing their concerns on social media. Comments such as “Tough when one of your best players is out as you close out the season” and “Eagles season is quickly turning ugly” highlight the emotional impact of Carter’s absence. One fan urged, “Hope he’s back ASAP!” while another remarked, “Yeah bro he sounds beat up. Take time to heal.”

This injury could have serious repercussions for the Eagles as they navigate the final stages of the regular season. With the playoffs looming, the team must rally without one of its key defensive players. Fans and analysts alike will be closely monitoring how the Eagles adapt in Carter’s absence and what this means for their playoff strategy.

As the situation develops, stay tuned for more updates on Carter’s recovery and the Eagles’ performance against the Chargers. The team will need to find a way to overcome this high-stakes challenge as they pursue postseason glory.